Single-step label-free nanowell immunoassay accurately quantifies serum stress hormones within minutes.
S Reza MahmoodiPengfei XieDaniel P ZachsErik J PetersonRachel S GrahamClaire R W KaiserHubert H LimMark G AllenMehdi JavanmardPublished in: Science advances (2021)
A non-faradaic label-free cortisol sensing platform is presented using a nanowell array design, in which the two probe electrodes are integrated within the nanowell structure. Rapid and low volume (≤5 μl) sensing was realized through functionalizing nanoscale volume wells with antibodies and monitoring the real-time binding events. A 28-well plate biochip was built on a glass substrate by sequential deposition, patterning, and etching steps to create a stack nanowell array sensor with an electrode gap of 40 nm. Sensor response for cortisol concentrations between 1 and 15 μg/dl in buffer solution was recorded, and a limit of detection of 0.5 μg/dl was achieved. Last, 65 human serum samples were collected to compare the response from human serum samples with results from the standard enzyme-linked immunosorbent assay (ELISA). These results confirm that nanowell array sensors could be a promising platform for point-of-care testing, where real-time, laboratory-quality diagnostic results are essential.
Keyphrases
- label free
- high throughput
- high resolution
- single cell
- solid state
- high density
- photodynamic therapy
- loop mediated isothermal amplification
- carbon nanotubes
- gold nanoparticles
- quantum dots
- atomic force microscopy
- stress induced
- binding protein
- transcription factor
- living cells
- reduced graphene oxide
- fluorescent probe